These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 17577900)

  • 21. NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.
    Hou L; Zagorski MG
    J Am Chem Soc; 2006 Jul; 128(29):9260-1. PubMed ID: 16848423
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular modeling of zinc and copper binding with Alzheimer's amyloid beta-peptide.
    Han D; Wang H; Yang P
    Biometals; 2008 Apr; 21(2):189-96. PubMed ID: 17629774
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid beta-Cu2+ complexes in both monomeric and fibrillar forms do not generate H2O2 catalytically but quench hydroxyl radicals.
    Nadal RC; Rigby SE; Viles JH
    Biochemistry; 2008 Nov; 47(44):11653-64. PubMed ID: 18847222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Copper catalyzed oxidation of Alzheimer Abeta.
    Atwood CS; Huang X; Khatri A; Scarpa RC; Kim YS; Moir RD; Tanzi RE; Roher AE; Bush AI
    Cell Mol Biol (Noisy-le-grand); 2000 Jun; 46(4):777-83. PubMed ID: 10875439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An analog of the human albumin N-terminus (Asp-Ala-His-Lys) prevents formation of copper-induced reactive oxygen species.
    Bar-Or D; Rael LT; Lau EP; Rao NK; Thomas GW; Winkler JV; Yukl RL; Kingston RG; Curtis CG
    Biochem Biophys Res Commun; 2001 Jun; 284(3):856-62. PubMed ID: 11396981
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substrate mediated reduction of copper-amyloid-beta complex in Alzheimer's disease.
    Streltsov VA; Varghese JN
    Chem Commun (Camb); 2008 Jul; (27):3169-71. PubMed ID: 18594731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling copper binding to the amyloid-β peptide at different pH: toward a molecular mechanism for Cu reduction.
    Furlan S; Hureau C; Faller P; La Penna G
    J Phys Chem B; 2012 Oct; 116(39):11899-910. PubMed ID: 22974015
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abeta40, either soluble or aggregated, is a remarkably potent antioxidant in cell-free oxidative systems.
    Baruch-Suchodolsky R; Fischer B
    Biochemistry; 2009 May; 48(20):4354-70. PubMed ID: 19320465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The heterogeneous nature of Cu2+ interactions with Alzheimer's amyloid-β peptide.
    Drew SC; Barnham KJ
    Acc Chem Res; 2011 Nov; 44(11):1146-55. PubMed ID: 21714485
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Redox reactions of copper complexes formed with different beta-amyloid peptides and their neuropathological [correction of neuropathalogical] relevance.
    Jiang D; Men L; Wang J; Zhang Y; Chickenyen S; Wang Y; Zhou F
    Biochemistry; 2007 Aug; 46(32):9270-82. PubMed ID: 17636872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. alphaB-crystallin competes with Alzheimer's disease beta-amyloid peptide for peptide-peptide interactions and induces oxidation of Abeta-Met35.
    Narayanan S; Kamps B; Boelens WC; Reif B
    FEBS Lett; 2006 Oct; 580(25):5941-6. PubMed ID: 17046756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibitory effect of copper(II) on zinc(II)-induced aggregation of amyloid beta-peptide.
    Suzuki K; Miura T; Takeuchi H
    Biochem Biophys Res Commun; 2001 Jul; 285(4):991-6. PubMed ID: 11467850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism of copper(II) inhibiting Alzheimer's amyloid beta-peptide from aggregation: a molecular dynamics investigation.
    Jiao Y; Yang P
    J Phys Chem B; 2007 Jul; 111(26):7646-55. PubMed ID: 17564430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metal swap between Zn7-metallothionein-3 and amyloid-beta-Cu protects against amyloid-beta toxicity.
    Meloni G; Sonois V; Delaine T; Guilloreau L; Gillet A; Teissié J; Faller P; Vasák M
    Nat Chem Biol; 2008 Jun; 4(6):366-72. PubMed ID: 18454142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Redox regulation of copper-metallothionein.
    Fabisiak JP; Tyurin VA; Tyurina YY; Borisenko GG; Korotaeva A; Pitt BR; Lazo JS; Kagan VE
    Arch Biochem Biophys; 1999 Mar; 363(1):171-81. PubMed ID: 10049512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A direct determination of the dissociation constant for the Cu(II) complex of amyloid beta 1-40 peptide.
    Rózga M; Kłoniecki M; Dadlez M; Bal W
    Chem Res Toxicol; 2010 Feb; 23(2):336-40. PubMed ID: 19911803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of chelators and iron ions on the production and degradation of H2O2 by beta-amyloid-copper complexes.
    Deraeve C; Pitie M; Meunier B
    J Inorg Biochem; 2006 Dec; 100(12):2117-26. PubMed ID: 17011628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abeta(25-35) and its C- and/or N-blocked derivatives: copper driven structural features and neurotoxicity.
    Giuffrida ML; Grasso G; Ruvo M; Pedone C; Saporito A; Marasco D; Pignataro B; Cascio C; Copani A; Rizzarelli E
    J Neurosci Res; 2007 Feb; 85(3):623-33. PubMed ID: 17131391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidation of cholesterol catalyzed by amyloid beta-peptide (Abeta)-Cu complex on lipid membrane.
    Yoshimoto N; Tasaki M; Shimanouchi T; Umakoshi H; Kuboi R
    J Biosci Bioeng; 2005 Oct; 100(4):455-9. PubMed ID: 16310737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of copper binding to the peptide amyloid-beta(1-16) associated with Alzheimer's disease.
    Ma QF; Hu J; Wu WH; Liu HD; Du JT; Fu Y; Wu YW; Lei P; Zhao YF; Li YM
    Biopolymers; 2006 Sep; 83(1):20-31. PubMed ID: 16615111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.